November 20th, 2014
Intention to Tweet: Does Social Media Exposure Matter for Journal Articles?
John Ryan, MD
Journals increasingly use social media to share medical information. After original research is published, the social media attention it receives correlates with how often it is cited. But does such attention enhance a journal article’s overall impact?
To address this question, my fellow researchers and I randomly assigned 243 consecutive original research articles published in Circulation during the past year to a “social media exposure” arm or a control arm. (Articles that had simultaneous press releases, AHA presentations, or Author profiles were excluded.)
On the day of publication, we tweeted about articles in the social media arm on the official Circulation Twitter page (@CircAHA) and the official Circulation Facebook page. Articles in the control arm received no formal, journal-based social media exposure. Here are examples of a tweet and a Facebook post that we have published during the past year:
With respect to the primary endpoint — article page views within 30 days — articles in the two arms showed no significant difference (median, 409 for social media exposure vs. 392 for control; P=0.80). Among basic science articles, social media exposure showed a trend toward greater page views, but the study was not powered or designed to detect a significant difference.
We think this social media strategy did not affect page views for three reasons:
- Researchers who are interested in articles in Circulation may already be inclined to read them on the journal’s website and not rely on social media to learn about journal articles.
- Cardiology still occupies a minute space on Twitter, where 350 million tweets are posted daily.
- Most Twitter and Facebook users access social media on their phones. In that setting, simply seeing a headline on a newsfeed may suffice, rather than accessing entire papers on the handheld device. Plus, Circulation followers may find our post and the key figure we provide to be enough to satisfy their interest.
According to our work, a social media strategy for Circulation did not increase the number of times an article is viewed. Further research is needed to help us understand and quantify the effect of social media on the reach of published cardiovascular research.
Note: Comments on this news story are closed, but please join the discussion about this topic over at Larry Husten’s discussion of the challenges those in traditional medicine have when using social media to promote research.
2 Responses to “Intention to Tweet: Does Social Media Exposure Matter for Journal Articles?”
NEJM — Recent Cardiology Articles- Thromboprophylaxis for Atrial Fibrillation in Patients with Drug-Eluting Stents February 12, 2026Stroke prevention is one of the pillars of treatment for patients with atrial fibrillation, and oral anticoagulation with a direct oral anticoagulant (DOAC) is now the preferred option for thromboprophylaxis.1 Nevertheless, patients with atrial fibrillation commonly have coexistent vascular disease, so they may present with an acute...
- Adenoviral Inciting Antigen and Somatic Hypermutation in VITT February 12, 2026VITT is caused by a somatic hypermutation of an anti–adenovirus pVII antibody that generates more avid binding of platelet factor 4 than of adenovirus pVII, its original target, which results in platelet activation.
- Case 5-2026: An 18-Year-Old Woman with Headache and Hypertension February 12, 2026An 18-year-old woman with chronic headaches was admitted to the pediatric intensive care unit for a hypertensive emergency. The potassium level was 2.0 mmol per liter. A diagnosis was made.
- Therapy for Atrial Fibrillation in Patients with Drug-Eluting Stents February 12, 2026In patients with atrial fibrillation and a drug-eluting stent placed at least 1 year earlier, monotherapy with a non–vitamin K antagonist oral anticoagulant was noninferior to combination therapy with clopidogrel for net adverse clinical events.
- LVAD February 5, 2026When a man ends up in the ED after having severed the driveline of his left ventricular assist device, the medical student on his team learns that sometimes a life saved is not the life the patient wants to live.
- Thromboprophylaxis for Atrial Fibrillation in Patients with Drug-Eluting Stents February 12, 2026
JR, this is a great and provocative study! Some thoughts…
– Does clicking on the link take you to the article, or do you have to go through a complicated signing in process?
– Could this be a failure of how Circulation is advertising the papers? Simply tweeting something or posting on facebook might not be enough. Do the people doing the facebooking/tweeting have a background in marketing? What if it was tweeted by someone in science who has a following?
– What are the other predictors of what gets circulation papers read? Is the journal not publishing enough papers that might be interesting to the reader?
Thanks Tariq for the feedback. Regarding your questions:
– clicking on the link does take you to the article (at least when you are within a University that has a Circ log in).
– The SoMe posts were done by the authors of the study- so not necessarily people trained in tweeting or with marketing background. And they were posted on the @CircAHA feed- which one criticism has been that the account seems impersonal.
– I think the journal is publishing interesting papers, I just think, to quote Dr. Fuster during our presentation, “cardiologists just aren’t reading anymore”.